Clinical imipenem non-susceptible Klebsiella pneumoniae isolates from China: Epidemiology, molecular characterization and in vitro activity of imipenem/relebactam
Harbouring the bla<sub>KPC-2</sub> gene was the dominant mechanism of IPMNS K. pneumoniae in China. Empirical imipenem/relebactam treatment could be considered when susceptibility or carbapenemase tests are not available.
Authors
- Jingjia Zhang (ORCID: https://orcid.org/0000-0002-8285-950X)
- Wei Kang (ORCID: https://orcid.org/0000-0002-7617-6323)
- Shiyu Chen (ORCID: https://orcid.org/0000-0002-2700-260X)
- Hui Zhang (ORCID: https://orcid.org/0000-0003-0162-8679)
- Ge Zhang (ORCID: https://orcid.org/0000-0002-7807-7695)
- Qian Zhang (ORCID: https://orcid.org/0000-0003-0472-4295)
- Pengcheng Li (ORCID: https://orcid.org/0000-0002-1778-7095)
- Yingchun Xu (ORCID: https://orcid.org/0000-0002-7126-9459)
- Qiwen Yang (ORCID: https://orcid.org/0009-0004-3996-5448)
- Peiyao Jia (ORCID: https://orcid.org/0000-0003-0585-9255)
- Xiaobing Chu
- Wei Yu (ORCID: https://orcid.org/0009-0003-3765-418X)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Shanghai Medical Information Center (CN)
Publication Details
- Journal
- Journal of Global Antimicrobial Resistance
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1016/j.jgar.2025.05.011
- Citations
- 2
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 1.18